Survival score to characterize prognosis in inoperable stage III NSCLC after chemoradiotherapy

類似資料

• Association of Planning Target Volume with Patient Outcome in Inoperable Stage III NSCLC Treated with Chemoradiotherapy: A Comprehensive Single-Center Analysis
  著者:: Karin, Monika, 等
  出版事項: (2020)
• Pattern-of-failure and salvage treatment analysis after chemoradiotherapy for inoperable stage III non-small cell lung cancer
  著者:: Taugner, Julian, 等
  出版事項: (2020)
• Implementation of durvalumab maintenance treatment after concurrent chemoradiotherapy in inoperable stage III non-small cell lung cancer (NSCLC)—a German radiation oncology survey
  著者:: Käsmann, Lukas, 等
  出版事項: (2020)
• Maximum standardized uptake value of primary tumor (SUVmax_PT) and horizontal range between two most distant PET-positive lymph nodes predict patient outcome in inoperable stage III NSCLC patients after chemoradiotherapy
  著者:: Roengvoraphoj, Olarn, 等
  出版事項: (2020)
• Durvalumab after Chemoradiotherapy for PD-L1 Expressing Inoperable Stage III NSCLC Leads to Significant Improvement of Local-Regional Control and Overall Survival in the Real-World Setting
  著者:: Taugner, Julian, 等
  出版事項: (2021)